Phase IV head-to-head randomised controlled trial comparing ingenol mebutate 0.015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp.

CONCLUSION: AKCLEAR 100, patient treatment satisfaction and effectiveness were significantly higher with IngMeb versus DS, demonstrating superiority of IngMeb for AK treatment on face/scalp (NCT02406014). This article is protected by copyright. All rights reserved. PMID: 29030864 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29030864?dopt=Abstract

Source: The British Journal of Dermatology - October 14, 2017 Category: Dermatology Authors: Stockfleth E, Harwood CA, Serra Guillén C, Larsson T, Østerdal ML, Skov T Tags: Br J Dermatol Source Type: research